It’s good to be the king: David Freese wows ’em at Macy’s

12 Comments

After his heroics in the World Series, you had to know that life was going to become very, very good for David Freese.

As a Cardinal playing in his native St. Louis, the World Series MVP might never again be forced to buy his own drink or pay for his own dinner, even if he regresses to Willie Bloomquist for the rest of his career.

From tooling around in his brand new Corvette, to hanging out on the “Tonight Show” with Justin Bieber (right), the offseason is going to be quite enjoyable for the 28-year-old third baseman.

And if you think I’m lying, check out this headline from the St. Louis Post-Dispatch: David Freese wows a Macy’s Galleria crowd.

Yeah that’s right, the Richmond Heights, Mo. Macy’s was abuzz on Wednesday, and I’m not exaggerating. According to the story, fans started getting in line the night before to snag one of the 275 wristbands that gave them a chance to take part in the event. The wristband gave the bearer the right to spend “at least $50 on Macy’s merchandise,” which you have to admit is quite a deal all by itself. (Think they sold any of these?)

But of course that’s not all they got, the big payoff being a signed baseball from their hero. Not too bad when you think about it, for the fans or for Freese.

Enjoy your new-found celebrity Mr. MVP. It’s good to be the king.

You can follow Bob on Twitter here, or if Facebook is your thing, be his friend here.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.